观察^(131)I治疗白细胞减少的Graves病的疗效及安全性
摘要
1资料与方法通过观察119例伴有白细胞减少的Gaves病患者131I疗后的疗效和安全,探讨131I治疗Gaves患者甲亢疗效与细胞恢复情况的关系。
出处
《中国医学工程》
2010年第4期78-78,共1页
China Medical Engineering
参考文献2
-
1沈绍群,李林.^(131)I治疗甲亢的新进展[J].华西医学,2006,21(3):620-621. 被引量：6
-
2Kita T, Yokoyama K, Kinuya S, et al. Single dose planning for radioiodine - 131 therapy of Graves" disease [ J ]. Ann Nucl Med, 2004, 18 (2): 151.
二级参考文献22
-
1Mariano G,Antonio T,Giuseppe B,et al.Comparison of Different Thyroid Committed Doses in Radioiodine Therapy for Graves,Hyperthyroidism.cancer biotherapy & radiopharmaceuticals[J].2005,20(2):218-223.
-
2Ahmad AM,Ahmad M,Young ET.Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis[J].Eur J Endocrinol,2002,146(6):767-775.
-
3Sabri O,Zimny M,Schulz G,et al.Success rate of radioiodine therapy in Graves' disease:the influence of thyrostatic medication[J].J Clin Endocrinol Metab,1999,84:1229-1233.
-
4Allahabadia A,Daykin J,Sheppard MC,et al.Radioiodine Treatment of Hyperthyroidism-Prognostic Factors for Outcome[J].J Clinical Endocrinol & Metab,2001,86(8):3611-3617.
-
5Andrade VA,Gross JL,Maia AL.The Effect of Methimazole Pretreatment on the Efficacy of Radioactive Iodine Therapy in Graves' Hyperthyroidism:One-Year Follow-Up of a Prospective,Randomized Study[J].J Clin Endocrinol & Metab,2001,86(8):3488-3493.
-
6Alexander EK,Larsen PR.High Dose ^131 I Therapy for the Treatment of Hyperthyroidism Caused by Graves' Disease[J].J Clin Endocrinol & Metab,2002,87(3):1073-1077.
-
7Imseis RE,Vanmiddlesworth L,Massie JD,et al.Pretreatment with Propylthiouracil But Not Methimazole Reduces the Therapeutic Efficacy of Iodine-131 in Hyperthyroidism[J].J Clin Endocrinol & Metab,1998,83(2):685-687.
-
8Kita T,Yokoyama K,Kinuya S,et al.Single dose planning for radioiodine-131 therapy of Graves' disease[J].Ann Nucl Med,2004,18(2):151-155.
-
9Ceccarelli C,Bencivelli W,Vitti P,et al.Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules:a 20 years' retrospective study[J].Clin Endocrinol(Oxf),2005,62(3):331-335.
-
10Walter MA,Christ-Crain M,Eckard B,et al.Radioiodine therapy in hyperthyroidism:inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome[J].Eur J Clin Invest,2004,34(5):365-370.
共引文献5
-
1崔力.^(131)I治疗Graves'病150例疗效观察与结果分析[J].吉林医学,2008,29(9):734-735. 被引量：1
-
2吕如锋,田奕,王睿,罗燕华.甲亢患者服^(131)I前后交感神经皮肤反应变化及意义[J].山东医药,2008,48(23):49-50.
-
3邓燕,章红.观察^(131)Ⅰ治疗白细胞减少的Graves病的疗效及安全性[J].标记免疫分析与临床,2011,18(4):276-277.
-
4王朋,代文莉,胡涛,严凯,胡伟,崔邦平.Graves病^(131)I治疗的研究进展[J].医学综述,2015,21(12):2194-2196. 被引量：2
-
5刘敏.低甲状腺摄碘率甲亢的^(131)Ⅰ治疗疗效分析[J].中国社区医师（医学专业）,2014,16(20):65-65. 被引量：2
-
1胡军,何金森,张海蒙,侯永健,李鼎.针药结合治疗Graves’病临床观察[J].针灸临床杂志,1994,10(2):36-37. 被引量：1
-
2于建华,侯媛媛,梁秀利,高晓梅.Graves'病患者血TNF RIA[J].放射免疫学杂志,1996,9(6):356-356. 被引量：1
-
3许文兵,朱元珏,郭盛祥,孙铁英,王虹,马毅,缪竞智,侯军,张桂兰.白三烯受体拮抗剂扎鲁司特治疗轻、中度哮喘疗效和安全性评价[J].中华结核和呼吸杂志,2000,23(3):164-165. 被引量：16
-
4欧文森,杨伟民,钟耀彬,候全基,周佩晓.胺碘酮和贝那普利联合用药治疗阵发性心房颤动的临床疗效和安全分析[J].北方药学,2017,14(2):158-159. 被引量：3
-
5史俊康.硝苯地平缓释片治疗慢性肾功能不全合并高血压疗效观察[J].青岛医药卫生,2014,46(6):437-439. 被引量：4
-
6吴海燕,周江红.虎杖治疗152例冠心病疗效观察[J].健康导报（医学版）,2015,20(9):66-66.
-
7莫测,王琼,黄嵘.麝香保心丸治疗冠心病心绞痛的疗效观察与评析[J].中成药,2004,26(B12):79-79. 被引量：1
-
8张卫军.华法林治疗老年非瓣膜病房颤抗凝临床分析[J].浙江医学,2012,34(12):1076-1077. 被引量：1
-
9应向苹,周江红.丹参治疗152例冠心病疗效观察[J].中国中医药咨讯,2011,3(18):161-161.
-
10马向阳.老年急性冠状动脉综合征患者介入术中应用替罗非班的疗效和安全性分析[J].中国医药指南,2015,13(20):98-99. 被引量：1
